Link to this page
Antibiotic Resistance Ontology
Last uploaded:
December 18, 2024
Jump to:
Preferred Name | betaxolol | |
Synonyms |
|
|
Definitions |
Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and angina, with a 50% inhibitory concentration (IC50) of 19.3 plus or minus 0.9 uM significantly inhibiting the hydrolytic activity of the NDM-1 enzyme and may represent a potential NDM-1 enzyme inhibitor. BET combined with meropenem (MEM) showed bactericidal synergism in vitro. BET inhibited NDM-1 by competitively binding to it and that it can be developed in combination with MEM as a new therapy. |
|
ID |
http://purl.obolibrary.org/obo/ARO_3007750 |
|
database_cross_reference |
PubChem:2369 ChEMBL:CHEMBL423 CAS:63659-18-7 ChEBI:3082
|
|
definition |
Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and angina, with a 50% inhibitory concentration (IC50) of 19.3 plus or minus 0.9 uM significantly inhibiting the hydrolytic activity of the NDM-1 enzyme and may represent a potential NDM-1 enzyme inhibitor. BET combined with meropenem (MEM) showed bactericidal synergism in vitro. BET inhibited NDM-1 by competitively binding to it and that it can be developed in combination with MEM as a new therapy.
|
|
has_obo_namespace |
antibiotic_resistance
|
|
id |
ARO:3007750
|
|
label |
betaxolol
|
|
notation |
ARO:3007750
|
|
prefLabel |
betaxolol
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping